Reasons for biomarker testing in NSCLC: An analysis of reasoning between 2021-2023 in early- vs. late-stage patients. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This ...
Low-molecular-weight heparins (LMWHs) are carbohydrate-based anticoagulants clinically used to treat thrombotic disorders, but impurities, structural heterogeneity or functional irreversibility can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback